Global Cell-free Tumor DNA Detection Market 2023 by Company, Regions, Type and Application, Forecast to 2029
Cell-free tumor DNA (circulating tumor DNA, ctDNA) testing, the so-called 'liquid biopsy'. ctDNA refers to the DNA released by tumor cells into the blood circulatory system, which contains information on tumor-derived mutations and gene variations. ctDNA is a tumor marker with broad application prospects, high sensitivity and high specificity, and is suitable for a variety of tumors, providing an opportunity for non-invasive sampling of tumors.
According to our (Global Info Research) latest study, the global Cell-free Tumor DNA Detection market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Cell-free Tumor DNA Detection market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cell-free Tumor DNA Detection market size and forecasts, in consumption value ($ Million), 2018-2029
Global Cell-free Tumor DNA Detection market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Cell-free Tumor DNA Detection market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Cell-free Tumor DNA Detection market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell-free Tumor DNA Detection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell-free Tumor DNA Detection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biocept Inc., Bio-Rad Laboratories Inc., Fluxion Biosciences Inc., F. Hoffmann-La Roche AG and Sysmex Europe SE, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Cell-free Tumor DNA Detection market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Cell-free Tumor DNA Detection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell-free Tumor DNA Detection, with revenue, gross margin and global market share of Cell-free Tumor DNA Detection from 2018 to 2023.
Chapter 3, the Cell-free Tumor DNA Detection competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cell-free Tumor DNA Detection market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell-free Tumor DNA Detection.
Chapter 13, to describe Cell-free Tumor DNA Detection research findings and conclusion.
According to our (Global Info Research) latest study, the global Cell-free Tumor DNA Detection market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Cell-free Tumor DNA Detection market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cell-free Tumor DNA Detection market size and forecasts, in consumption value ($ Million), 2018-2029
Global Cell-free Tumor DNA Detection market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Cell-free Tumor DNA Detection market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Cell-free Tumor DNA Detection market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell-free Tumor DNA Detection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell-free Tumor DNA Detection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biocept Inc., Bio-Rad Laboratories Inc., Fluxion Biosciences Inc., F. Hoffmann-La Roche AG and Sysmex Europe SE, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Cell-free Tumor DNA Detection market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Droplet Digital Polymerase Chain Reaction
- Tagged-Amplicon Deep Sequencing
- Others
- Breast Cancer
- Stomach Cancer
- Liver Cancer
- Other
- Biocept Inc.
- Bio-Rad Laboratories Inc.
- Fluxion Biosciences Inc.
- F. Hoffmann-La Roche AG
- Sysmex Europe SE
- Qiagen
- NeoGenomics Laboratories Inc.
- Menarini Silicon Biosystems
- Illumina Inc.
- Guardant Health Inc.
- Shanghai Biotecan Medical Diagnostics Co.,Ltd.
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Cell-free Tumor DNA Detection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell-free Tumor DNA Detection, with revenue, gross margin and global market share of Cell-free Tumor DNA Detection from 2018 to 2023.
Chapter 3, the Cell-free Tumor DNA Detection competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cell-free Tumor DNA Detection market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell-free Tumor DNA Detection.
Chapter 13, to describe Cell-free Tumor DNA Detection research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Cell-free Tumor DNA Detection
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cell-free Tumor DNA Detection by Type
1.3.1 Overview: Global Cell-free Tumor DNA Detection Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Cell-free Tumor DNA Detection Consumption Value Market Share by Type in 2022
1.3.3 Droplet Digital Polymerase Chain Reaction
1.3.4 Tagged-Amplicon Deep Sequencing
1.3.5 Others
1.4 Global Cell-free Tumor DNA Detection Market by Application
1.4.1 Overview: Global Cell-free Tumor DNA Detection Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Breast Cancer
1.4.3 Stomach Cancer
1.4.4 Liver Cancer
1.4.5 Other
1.5 Global Cell-free Tumor DNA Detection Market Size & Forecast
1.6 Global Cell-free Tumor DNA Detection Market Size and Forecast by Region
1.6.1 Global Cell-free Tumor DNA Detection Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Cell-free Tumor DNA Detection Market Size by Region, (2018-2029)
1.6.3 North America Cell-free Tumor DNA Detection Market Size and Prospect (2018-2029)
1.6.4 Europe Cell-free Tumor DNA Detection Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Cell-free Tumor DNA Detection Market Size and Prospect (2018-2029)
1.6.6 South America Cell-free Tumor DNA Detection Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Cell-free Tumor DNA Detection Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Biocept Inc.
2.1.1 Biocept Inc. Details
2.1.2 Biocept Inc. Major Business
2.1.3 Biocept Inc. Cell-free Tumor DNA Detection Product and Solutions
2.1.4 Biocept Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Biocept Inc. Recent Developments and Future Plans
2.2 Bio-Rad Laboratories Inc.
2.2.1 Bio-Rad Laboratories Inc. Details
2.2.2 Bio-Rad Laboratories Inc. Major Business
2.2.3 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Product and Solutions
2.2.4 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bio-Rad Laboratories Inc. Recent Developments and Future Plans
2.3 Fluxion Biosciences Inc.
2.3.1 Fluxion Biosciences Inc. Details
2.3.2 Fluxion Biosciences Inc. Major Business
2.3.3 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Product and Solutions
2.3.4 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Fluxion Biosciences Inc. Recent Developments and Future Plans
2.4 F. Hoffmann-La Roche AG
2.4.1 F. Hoffmann-La Roche AG Details
2.4.2 F. Hoffmann-La Roche AG Major Business
2.4.3 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Product and Solutions
2.4.4 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 F. Hoffmann-La Roche AG Recent Developments and Future Plans
2.5 Sysmex Europe SE
2.5.1 Sysmex Europe SE Details
2.5.2 Sysmex Europe SE Major Business
2.5.3 Sysmex Europe SE Cell-free Tumor DNA Detection Product and Solutions
2.5.4 Sysmex Europe SE Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sysmex Europe SE Recent Developments and Future Plans
2.6 Qiagen
2.6.1 Qiagen Details
2.6.2 Qiagen Major Business
2.6.3 Qiagen Cell-free Tumor DNA Detection Product and Solutions
2.6.4 Qiagen Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Qiagen Recent Developments and Future Plans
2.7 NeoGenomics Laboratories Inc.
2.7.1 NeoGenomics Laboratories Inc. Details
2.7.2 NeoGenomics Laboratories Inc. Major Business
2.7.3 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Product and Solutions
2.7.4 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 NeoGenomics Laboratories Inc. Recent Developments and Future Plans
2.8 Menarini Silicon Biosystems
2.8.1 Menarini Silicon Biosystems Details
2.8.2 Menarini Silicon Biosystems Major Business
2.8.3 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Product and Solutions
2.8.4 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Menarini Silicon Biosystems Recent Developments and Future Plans
2.9 Illumina Inc.
2.9.1 Illumina Inc. Details
2.9.2 Illumina Inc. Major Business
2.9.3 Illumina Inc. Cell-free Tumor DNA Detection Product and Solutions
2.9.4 Illumina Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Illumina Inc. Recent Developments and Future Plans
2.10 Guardant Health Inc.
2.10.1 Guardant Health Inc. Details
2.10.2 Guardant Health Inc. Major Business
2.10.3 Guardant Health Inc. Cell-free Tumor DNA Detection Product and Solutions
2.10.4 Guardant Health Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Guardant Health Inc. Recent Developments and Future Plans
2.11 Shanghai Biotecan Medical Diagnostics Co.,Ltd.
2.11.1 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Details
2.11.2 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Major Business
2.11.3 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Product and Solutions
2.11.4 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Cell-free Tumor DNA Detection Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Cell-free Tumor DNA Detection by Company Revenue
3.2.2 Top 3 Cell-free Tumor DNA Detection Players Market Share in 2022
3.2.3 Top 6 Cell-free Tumor DNA Detection Players Market Share in 2022
3.3 Cell-free Tumor DNA Detection Market: Overall Company Footprint Analysis
3.3.1 Cell-free Tumor DNA Detection Market: Region Footprint
3.3.2 Cell-free Tumor DNA Detection Market: Company Product Type Footprint
3.3.3 Cell-free Tumor DNA Detection Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Cell-free Tumor DNA Detection Consumption Value and Market Share by Type (2018-2023)
4.2 Global Cell-free Tumor DNA Detection Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Cell-free Tumor DNA Detection Consumption Value Market Share by Application (2018-2023)
5.2 Global Cell-free Tumor DNA Detection Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Cell-free Tumor DNA Detection Consumption Value by Type (2018-2029)
6.2 North America Cell-free Tumor DNA Detection Consumption Value by Application (2018-2029)
6.3 North America Cell-free Tumor DNA Detection Market Size by Country
6.3.1 North America Cell-free Tumor DNA Detection Consumption Value by Country (2018-2029)
6.3.2 United States Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
6.3.3 Canada Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
6.3.4 Mexico Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Cell-free Tumor DNA Detection Consumption Value by Type (2018-2029)
7.2 Europe Cell-free Tumor DNA Detection Consumption Value by Application (2018-2029)
7.3 Europe Cell-free Tumor DNA Detection Market Size by Country
7.3.1 Europe Cell-free Tumor DNA Detection Consumption Value by Country (2018-2029)
7.3.2 Germany Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
7.3.3 France Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
7.3.5 Russia Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
7.3.6 Italy Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Cell-free Tumor DNA Detection Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Cell-free Tumor DNA Detection Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Cell-free Tumor DNA Detection Market Size by Region
8.3.1 Asia-Pacific Cell-free Tumor DNA Detection Consumption Value by Region (2018-2029)
8.3.2 China Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
8.3.3 Japan Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
8.3.4 South Korea Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
8.3.5 India Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
8.3.7 Australia Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Cell-free Tumor DNA Detection Consumption Value by Type (2018-2029)
9.2 South America Cell-free Tumor DNA Detection Consumption Value by Application (2018-2029)
9.3 South America Cell-free Tumor DNA Detection Market Size by Country
9.3.1 South America Cell-free Tumor DNA Detection Consumption Value by Country (2018-2029)
9.3.2 Brazil Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
9.3.3 Argentina Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cell-free Tumor DNA Detection Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Cell-free Tumor DNA Detection Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Cell-free Tumor DNA Detection Market Size by Country
10.3.1 Middle East & Africa Cell-free Tumor DNA Detection Consumption Value by Country (2018-2029)
10.3.2 Turkey Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
10.3.4 UAE Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Cell-free Tumor DNA Detection Market Drivers
11.2 Cell-free Tumor DNA Detection Market Restraints
11.3 Cell-free Tumor DNA Detection Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Cell-free Tumor DNA Detection Industry Chain
12.2 Cell-free Tumor DNA Detection Upstream Analysis
12.3 Cell-free Tumor DNA Detection Midstream Analysis
12.4 Cell-free Tumor DNA Detection Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Cell-free Tumor DNA Detection
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cell-free Tumor DNA Detection by Type
1.3.1 Overview: Global Cell-free Tumor DNA Detection Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Cell-free Tumor DNA Detection Consumption Value Market Share by Type in 2022
1.3.3 Droplet Digital Polymerase Chain Reaction
1.3.4 Tagged-Amplicon Deep Sequencing
1.3.5 Others
1.4 Global Cell-free Tumor DNA Detection Market by Application
1.4.1 Overview: Global Cell-free Tumor DNA Detection Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Breast Cancer
1.4.3 Stomach Cancer
1.4.4 Liver Cancer
1.4.5 Other
1.5 Global Cell-free Tumor DNA Detection Market Size & Forecast
1.6 Global Cell-free Tumor DNA Detection Market Size and Forecast by Region
1.6.1 Global Cell-free Tumor DNA Detection Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Cell-free Tumor DNA Detection Market Size by Region, (2018-2029)
1.6.3 North America Cell-free Tumor DNA Detection Market Size and Prospect (2018-2029)
1.6.4 Europe Cell-free Tumor DNA Detection Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Cell-free Tumor DNA Detection Market Size and Prospect (2018-2029)
1.6.6 South America Cell-free Tumor DNA Detection Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Cell-free Tumor DNA Detection Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Biocept Inc.
2.1.1 Biocept Inc. Details
2.1.2 Biocept Inc. Major Business
2.1.3 Biocept Inc. Cell-free Tumor DNA Detection Product and Solutions
2.1.4 Biocept Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Biocept Inc. Recent Developments and Future Plans
2.2 Bio-Rad Laboratories Inc.
2.2.1 Bio-Rad Laboratories Inc. Details
2.2.2 Bio-Rad Laboratories Inc. Major Business
2.2.3 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Product and Solutions
2.2.4 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bio-Rad Laboratories Inc. Recent Developments and Future Plans
2.3 Fluxion Biosciences Inc.
2.3.1 Fluxion Biosciences Inc. Details
2.3.2 Fluxion Biosciences Inc. Major Business
2.3.3 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Product and Solutions
2.3.4 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Fluxion Biosciences Inc. Recent Developments and Future Plans
2.4 F. Hoffmann-La Roche AG
2.4.1 F. Hoffmann-La Roche AG Details
2.4.2 F. Hoffmann-La Roche AG Major Business
2.4.3 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Product and Solutions
2.4.4 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 F. Hoffmann-La Roche AG Recent Developments and Future Plans
2.5 Sysmex Europe SE
2.5.1 Sysmex Europe SE Details
2.5.2 Sysmex Europe SE Major Business
2.5.3 Sysmex Europe SE Cell-free Tumor DNA Detection Product and Solutions
2.5.4 Sysmex Europe SE Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sysmex Europe SE Recent Developments and Future Plans
2.6 Qiagen
2.6.1 Qiagen Details
2.6.2 Qiagen Major Business
2.6.3 Qiagen Cell-free Tumor DNA Detection Product and Solutions
2.6.4 Qiagen Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Qiagen Recent Developments and Future Plans
2.7 NeoGenomics Laboratories Inc.
2.7.1 NeoGenomics Laboratories Inc. Details
2.7.2 NeoGenomics Laboratories Inc. Major Business
2.7.3 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Product and Solutions
2.7.4 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 NeoGenomics Laboratories Inc. Recent Developments and Future Plans
2.8 Menarini Silicon Biosystems
2.8.1 Menarini Silicon Biosystems Details
2.8.2 Menarini Silicon Biosystems Major Business
2.8.3 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Product and Solutions
2.8.4 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Menarini Silicon Biosystems Recent Developments and Future Plans
2.9 Illumina Inc.
2.9.1 Illumina Inc. Details
2.9.2 Illumina Inc. Major Business
2.9.3 Illumina Inc. Cell-free Tumor DNA Detection Product and Solutions
2.9.4 Illumina Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Illumina Inc. Recent Developments and Future Plans
2.10 Guardant Health Inc.
2.10.1 Guardant Health Inc. Details
2.10.2 Guardant Health Inc. Major Business
2.10.3 Guardant Health Inc. Cell-free Tumor DNA Detection Product and Solutions
2.10.4 Guardant Health Inc. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Guardant Health Inc. Recent Developments and Future Plans
2.11 Shanghai Biotecan Medical Diagnostics Co.,Ltd.
2.11.1 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Details
2.11.2 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Major Business
2.11.3 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Product and Solutions
2.11.4 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Cell-free Tumor DNA Detection Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Cell-free Tumor DNA Detection by Company Revenue
3.2.2 Top 3 Cell-free Tumor DNA Detection Players Market Share in 2022
3.2.3 Top 6 Cell-free Tumor DNA Detection Players Market Share in 2022
3.3 Cell-free Tumor DNA Detection Market: Overall Company Footprint Analysis
3.3.1 Cell-free Tumor DNA Detection Market: Region Footprint
3.3.2 Cell-free Tumor DNA Detection Market: Company Product Type Footprint
3.3.3 Cell-free Tumor DNA Detection Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Cell-free Tumor DNA Detection Consumption Value and Market Share by Type (2018-2023)
4.2 Global Cell-free Tumor DNA Detection Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Cell-free Tumor DNA Detection Consumption Value Market Share by Application (2018-2023)
5.2 Global Cell-free Tumor DNA Detection Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Cell-free Tumor DNA Detection Consumption Value by Type (2018-2029)
6.2 North America Cell-free Tumor DNA Detection Consumption Value by Application (2018-2029)
6.3 North America Cell-free Tumor DNA Detection Market Size by Country
6.3.1 North America Cell-free Tumor DNA Detection Consumption Value by Country (2018-2029)
6.3.2 United States Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
6.3.3 Canada Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
6.3.4 Mexico Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Cell-free Tumor DNA Detection Consumption Value by Type (2018-2029)
7.2 Europe Cell-free Tumor DNA Detection Consumption Value by Application (2018-2029)
7.3 Europe Cell-free Tumor DNA Detection Market Size by Country
7.3.1 Europe Cell-free Tumor DNA Detection Consumption Value by Country (2018-2029)
7.3.2 Germany Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
7.3.3 France Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
7.3.5 Russia Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
7.3.6 Italy Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Cell-free Tumor DNA Detection Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Cell-free Tumor DNA Detection Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Cell-free Tumor DNA Detection Market Size by Region
8.3.1 Asia-Pacific Cell-free Tumor DNA Detection Consumption Value by Region (2018-2029)
8.3.2 China Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
8.3.3 Japan Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
8.3.4 South Korea Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
8.3.5 India Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
8.3.7 Australia Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Cell-free Tumor DNA Detection Consumption Value by Type (2018-2029)
9.2 South America Cell-free Tumor DNA Detection Consumption Value by Application (2018-2029)
9.3 South America Cell-free Tumor DNA Detection Market Size by Country
9.3.1 South America Cell-free Tumor DNA Detection Consumption Value by Country (2018-2029)
9.3.2 Brazil Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
9.3.3 Argentina Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cell-free Tumor DNA Detection Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Cell-free Tumor DNA Detection Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Cell-free Tumor DNA Detection Market Size by Country
10.3.1 Middle East & Africa Cell-free Tumor DNA Detection Consumption Value by Country (2018-2029)
10.3.2 Turkey Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
10.3.4 UAE Cell-free Tumor DNA Detection Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Cell-free Tumor DNA Detection Market Drivers
11.2 Cell-free Tumor DNA Detection Market Restraints
11.3 Cell-free Tumor DNA Detection Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Cell-free Tumor DNA Detection Industry Chain
12.2 Cell-free Tumor DNA Detection Upstream Analysis
12.3 Cell-free Tumor DNA Detection Midstream Analysis
12.4 Cell-free Tumor DNA Detection Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Cell-free Tumor DNA Detection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Cell-free Tumor DNA Detection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Cell-free Tumor DNA Detection Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Cell-free Tumor DNA Detection Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Biocept Inc. Company Information, Head Office, and Major Competitors
Table 6. Biocept Inc. Major Business
Table 7. Biocept Inc. Cell-free Tumor DNA Detection Product and Solutions
Table 8. Biocept Inc. Cell-free Tumor DNA Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Biocept Inc. Recent Developments and Future Plans
Table 10. Bio-Rad Laboratories Inc. Company Information, Head Office, and Major Competitors
Table 11. Bio-Rad Laboratories Inc. Major Business
Table 12. Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Product and Solutions
Table 13. Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Bio-Rad Laboratories Inc. Recent Developments and Future Plans
Table 15. Fluxion Biosciences Inc. Company Information, Head Office, and Major Competitors
Table 16. Fluxion Biosciences Inc. Major Business
Table 17. Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Product and Solutions
Table 18. Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Fluxion Biosciences Inc. Recent Developments and Future Plans
Table 20. F. Hoffmann-La Roche AG Company Information, Head Office, and Major Competitors
Table 21. F. Hoffmann-La Roche AG Major Business
Table 22. F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Product and Solutions
Table 23. F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. F. Hoffmann-La Roche AG Recent Developments and Future Plans
Table 25. Sysmex Europe SE Company Information, Head Office, and Major Competitors
Table 26. Sysmex Europe SE Major Business
Table 27. Sysmex Europe SE Cell-free Tumor DNA Detection Product and Solutions
Table 28. Sysmex Europe SE Cell-free Tumor DNA Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Sysmex Europe SE Recent Developments and Future Plans
Table 30. Qiagen Company Information, Head Office, and Major Competitors
Table 31. Qiagen Major Business
Table 32. Qiagen Cell-free Tumor DNA Detection Product and Solutions
Table 33. Qiagen Cell-free Tumor DNA Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Qiagen Recent Developments and Future Plans
Table 35. NeoGenomics Laboratories Inc. Company Information, Head Office, and Major Competitors
Table 36. NeoGenomics Laboratories Inc. Major Business
Table 37. NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Product and Solutions
Table 38. NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. NeoGenomics Laboratories Inc. Recent Developments and Future Plans
Table 40. Menarini Silicon Biosystems Company Information, Head Office, and Major Competitors
Table 41. Menarini Silicon Biosystems Major Business
Table 42. Menarini Silicon Biosystems Cell-free Tumor DNA Detection Product and Solutions
Table 43. Menarini Silicon Biosystems Cell-free Tumor DNA Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Menarini Silicon Biosystems Recent Developments and Future Plans
Table 45. Illumina Inc. Company Information, Head Office, and Major Competitors
Table 46. Illumina Inc. Major Business
Table 47. Illumina Inc. Cell-free Tumor DNA Detection Product and Solutions
Table 48. Illumina Inc. Cell-free Tumor DNA Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Illumina Inc. Recent Developments and Future Plans
Table 50. Guardant Health Inc. Company Information, Head Office, and Major Competitors
Table 51. Guardant Health Inc. Major Business
Table 52. Guardant Health Inc. Cell-free Tumor DNA Detection Product and Solutions
Table 53. Guardant Health Inc. Cell-free Tumor DNA Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Guardant Health Inc. Recent Developments and Future Plans
Table 55. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 56. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Major Business
Table 57. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Product and Solutions
Table 58. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Recent Developments and Future Plans
Table 60. Global Cell-free Tumor DNA Detection Revenue (USD Million) by Players (2018-2023)
Table 61. Global Cell-free Tumor DNA Detection Revenue Share by Players (2018-2023)
Table 62. Breakdown of Cell-free Tumor DNA Detection by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Cell-free Tumor DNA Detection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 64. Head Office of Key Cell-free Tumor DNA Detection Players
Table 65. Cell-free Tumor DNA Detection Market: Company Product Type Footprint
Table 66. Cell-free Tumor DNA Detection Market: Company Product Application Footprint
Table 67. Cell-free Tumor DNA Detection New Market Entrants and Barriers to Market Entry
Table 68. Cell-free Tumor DNA Detection Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Cell-free Tumor DNA Detection Consumption Value (USD Million) by Type (2018-2023)
Table 70. Global Cell-free Tumor DNA Detection Consumption Value Share by Type (2018-2023)
Table 71. Global Cell-free Tumor DNA Detection Consumption Value Forecast by Type (2024-2029)
Table 72. Global Cell-free Tumor DNA Detection Consumption Value by Application (2018-2023)
Table 73. Global Cell-free Tumor DNA Detection Consumption Value Forecast by Application (2024-2029)
Table 74. North America Cell-free Tumor DNA Detection Consumption Value by Type (2018-2023) & (USD Million)
Table 75. North America Cell-free Tumor DNA Detection Consumption Value by Type (2024-2029) & (USD Million)
Table 76. North America Cell-free Tumor DNA Detection Consumption Value by Application (2018-2023) & (USD Million)
Table 77. North America Cell-free Tumor DNA Detection Consumption Value by Application (2024-2029) & (USD Million)
Table 78. North America Cell-free Tumor DNA Detection Consumption Value by Country (2018-2023) & (USD Million)
Table 79. North America Cell-free Tumor DNA Detection Consumption Value by Country (2024-2029) & (USD Million)
Table 80. Europe Cell-free Tumor DNA Detection Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Europe Cell-free Tumor DNA Detection Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Europe Cell-free Tumor DNA Detection Consumption Value by Application (2018-2023) & (USD Million)
Table 83. Europe Cell-free Tumor DNA Detection Consumption Value by Application (2024-2029) & (USD Million)
Table 84. Europe Cell-free Tumor DNA Detection Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Cell-free Tumor DNA Detection Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Cell-free Tumor DNA Detection Consumption Value by Type (2018-2023) & (USD Million)
Table 87. Asia-Pacific Cell-free Tumor DNA Detection Consumption Value by Type (2024-2029) & (USD Million)
Table 88. Asia-Pacific Cell-free Tumor DNA Detection Consumption Value by Application (2018-2023) & (USD Million)
Table 89. Asia-Pacific Cell-free Tumor DNA Detection Consumption Value by Application (2024-2029) & (USD Million)
Table 90. Asia-Pacific Cell-free Tumor DNA Detection Consumption Value by Region (2018-2023) & (USD Million)
Table 91. Asia-Pacific Cell-free Tumor DNA Detection Consumption Value by Region (2024-2029) & (USD Million)
Table 92. South America Cell-free Tumor DNA Detection Consumption Value by Type (2018-2023) & (USD Million)
Table 93. South America Cell-free Tumor DNA Detection Consumption Value by Type (2024-2029) & (USD Million)
Table 94. South America Cell-free Tumor DNA Detection Consumption Value by Application (2018-2023) & (USD Million)
Table 95. South America Cell-free Tumor DNA Detection Consumption Value by Application (2024-2029) & (USD Million)
Table 96. South America Cell-free Tumor DNA Detection Consumption Value by Country (2018-2023) & (USD Million)
Table 97. South America Cell-free Tumor DNA Detection Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Middle East & Africa Cell-free Tumor DNA Detection Consumption Value by Type (2018-2023) & (USD Million)
Table 99. Middle East & Africa Cell-free Tumor DNA Detection Consumption Value by Type (2024-2029) & (USD Million)
Table 100. Middle East & Africa Cell-free Tumor DNA Detection Consumption Value by Application (2018-2023) & (USD Million)
Table 101. Middle East & Africa Cell-free Tumor DNA Detection Consumption Value by Application (2024-2029) & (USD Million)
Table 102. Middle East & Africa Cell-free Tumor DNA Detection Consumption Value by Country (2018-2023) & (USD Million)
Table 103. Middle East & Africa Cell-free Tumor DNA Detection Consumption Value by Country (2024-2029) & (USD Million)
Table 104. Cell-free Tumor DNA Detection Raw Material
Table 105. Key Suppliers of Cell-free Tumor DNA Detection Raw Materials
Table 1. Global Cell-free Tumor DNA Detection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Cell-free Tumor DNA Detection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Cell-free Tumor DNA Detection Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Cell-free Tumor DNA Detection Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Biocept Inc. Company Information, Head Office, and Major Competitors
Table 6. Biocept Inc. Major Business
Table 7. Biocept Inc. Cell-free Tumor DNA Detection Product and Solutions
Table 8. Biocept Inc. Cell-free Tumor DNA Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Biocept Inc. Recent Developments and Future Plans
Table 10. Bio-Rad Laboratories Inc. Company Information, Head Office, and Major Competitors
Table 11. Bio-Rad Laboratories Inc. Major Business
Table 12. Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Product and Solutions
Table 13. Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Bio-Rad Laboratories Inc. Recent Developments and Future Plans
Table 15. Fluxion Biosciences Inc. Company Information, Head Office, and Major Competitors
Table 16. Fluxion Biosciences Inc. Major Business
Table 17. Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Product and Solutions
Table 18. Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Fluxion Biosciences Inc. Recent Developments and Future Plans
Table 20. F. Hoffmann-La Roche AG Company Information, Head Office, and Major Competitors
Table 21. F. Hoffmann-La Roche AG Major Business
Table 22. F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Product and Solutions
Table 23. F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. F. Hoffmann-La Roche AG Recent Developments and Future Plans
Table 25. Sysmex Europe SE Company Information, Head Office, and Major Competitors
Table 26. Sysmex Europe SE Major Business
Table 27. Sysmex Europe SE Cell-free Tumor DNA Detection Product and Solutions
Table 28. Sysmex Europe SE Cell-free Tumor DNA Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Sysmex Europe SE Recent Developments and Future Plans
Table 30. Qiagen Company Information, Head Office, and Major Competitors
Table 31. Qiagen Major Business
Table 32. Qiagen Cell-free Tumor DNA Detection Product and Solutions
Table 33. Qiagen Cell-free Tumor DNA Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Qiagen Recent Developments and Future Plans
Table 35. NeoGenomics Laboratories Inc. Company Information, Head Office, and Major Competitors
Table 36. NeoGenomics Laboratories Inc. Major Business
Table 37. NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Product and Solutions
Table 38. NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. NeoGenomics Laboratories Inc. Recent Developments and Future Plans
Table 40. Menarini Silicon Biosystems Company Information, Head Office, and Major Competitors
Table 41. Menarini Silicon Biosystems Major Business
Table 42. Menarini Silicon Biosystems Cell-free Tumor DNA Detection Product and Solutions
Table 43. Menarini Silicon Biosystems Cell-free Tumor DNA Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Menarini Silicon Biosystems Recent Developments and Future Plans
Table 45. Illumina Inc. Company Information, Head Office, and Major Competitors
Table 46. Illumina Inc. Major Business
Table 47. Illumina Inc. Cell-free Tumor DNA Detection Product and Solutions
Table 48. Illumina Inc. Cell-free Tumor DNA Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Illumina Inc. Recent Developments and Future Plans
Table 50. Guardant Health Inc. Company Information, Head Office, and Major Competitors
Table 51. Guardant Health Inc. Major Business
Table 52. Guardant Health Inc. Cell-free Tumor DNA Detection Product and Solutions
Table 53. Guardant Health Inc. Cell-free Tumor DNA Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Guardant Health Inc. Recent Developments and Future Plans
Table 55. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 56. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Major Business
Table 57. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Product and Solutions
Table 58. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Recent Developments and Future Plans
Table 60. Global Cell-free Tumor DNA Detection Revenue (USD Million) by Players (2018-2023)
Table 61. Global Cell-free Tumor DNA Detection Revenue Share by Players (2018-2023)
Table 62. Breakdown of Cell-free Tumor DNA Detection by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Cell-free Tumor DNA Detection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 64. Head Office of Key Cell-free Tumor DNA Detection Players
Table 65. Cell-free Tumor DNA Detection Market: Company Product Type Footprint
Table 66. Cell-free Tumor DNA Detection Market: Company Product Application Footprint
Table 67. Cell-free Tumor DNA Detection New Market Entrants and Barriers to Market Entry
Table 68. Cell-free Tumor DNA Detection Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Cell-free Tumor DNA Detection Consumption Value (USD Million) by Type (2018-2023)
Table 70. Global Cell-free Tumor DNA Detection Consumption Value Share by Type (2018-2023)
Table 71. Global Cell-free Tumor DNA Detection Consumption Value Forecast by Type (2024-2029)
Table 72. Global Cell-free Tumor DNA Detection Consumption Value by Application (2018-2023)
Table 73. Global Cell-free Tumor DNA Detection Consumption Value Forecast by Application (2024-2029)
Table 74. North America Cell-free Tumor DNA Detection Consumption Value by Type (2018-2023) & (USD Million)
Table 75. North America Cell-free Tumor DNA Detection Consumption Value by Type (2024-2029) & (USD Million)
Table 76. North America Cell-free Tumor DNA Detection Consumption Value by Application (2018-2023) & (USD Million)
Table 77. North America Cell-free Tumor DNA Detection Consumption Value by Application (2024-2029) & (USD Million)
Table 78. North America Cell-free Tumor DNA Detection Consumption Value by Country (2018-2023) & (USD Million)
Table 79. North America Cell-free Tumor DNA Detection Consumption Value by Country (2024-2029) & (USD Million)
Table 80. Europe Cell-free Tumor DNA Detection Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Europe Cell-free Tumor DNA Detection Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Europe Cell-free Tumor DNA Detection Consumption Value by Application (2018-2023) & (USD Million)
Table 83. Europe Cell-free Tumor DNA Detection Consumption Value by Application (2024-2029) & (USD Million)
Table 84. Europe Cell-free Tumor DNA Detection Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Cell-free Tumor DNA Detection Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Cell-free Tumor DNA Detection Consumption Value by Type (2018-2023) & (USD Million)
Table 87. Asia-Pacific Cell-free Tumor DNA Detection Consumption Value by Type (2024-2029) & (USD Million)
Table 88. Asia-Pacific Cell-free Tumor DNA Detection Consumption Value by Application (2018-2023) & (USD Million)
Table 89. Asia-Pacific Cell-free Tumor DNA Detection Consumption Value by Application (2024-2029) & (USD Million)
Table 90. Asia-Pacific Cell-free Tumor DNA Detection Consumption Value by Region (2018-2023) & (USD Million)
Table 91. Asia-Pacific Cell-free Tumor DNA Detection Consumption Value by Region (2024-2029) & (USD Million)
Table 92. South America Cell-free Tumor DNA Detection Consumption Value by Type (2018-2023) & (USD Million)
Table 93. South America Cell-free Tumor DNA Detection Consumption Value by Type (2024-2029) & (USD Million)
Table 94. South America Cell-free Tumor DNA Detection Consumption Value by Application (2018-2023) & (USD Million)
Table 95. South America Cell-free Tumor DNA Detection Consumption Value by Application (2024-2029) & (USD Million)
Table 96. South America Cell-free Tumor DNA Detection Consumption Value by Country (2018-2023) & (USD Million)
Table 97. South America Cell-free Tumor DNA Detection Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Middle East & Africa Cell-free Tumor DNA Detection Consumption Value by Type (2018-2023) & (USD Million)
Table 99. Middle East & Africa Cell-free Tumor DNA Detection Consumption Value by Type (2024-2029) & (USD Million)
Table 100. Middle East & Africa Cell-free Tumor DNA Detection Consumption Value by Application (2018-2023) & (USD Million)
Table 101. Middle East & Africa Cell-free Tumor DNA Detection Consumption Value by Application (2024-2029) & (USD Million)
Table 102. Middle East & Africa Cell-free Tumor DNA Detection Consumption Value by Country (2018-2023) & (USD Million)
Table 103. Middle East & Africa Cell-free Tumor DNA Detection Consumption Value by Country (2024-2029) & (USD Million)
Table 104. Cell-free Tumor DNA Detection Raw Material
Table 105. Key Suppliers of Cell-free Tumor DNA Detection Raw Materials
LIST OF FIGURES
Figure 1. Cell-free Tumor DNA Detection Picture
Figure 2. Global Cell-free Tumor DNA Detection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Cell-free Tumor DNA Detection Consumption Value Market Share by Type in 2022
Figure 4. Droplet Digital Polymerase Chain Reaction
Figure 5. Tagged-Amplicon Deep Sequencing
Figure 6. Others
Figure 7. Global Cell-free Tumor DNA Detection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Cell-free Tumor DNA Detection Consumption Value Market Share by Application in 2022
Figure 9. Breast Cancer Picture
Figure 10. Stomach Cancer Picture
Figure 11. Liver Cancer Picture
Figure 12. Other Picture
Figure 13. Global Cell-free Tumor DNA Detection Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Cell-free Tumor DNA Detection Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Cell-free Tumor DNA Detection Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Cell-free Tumor DNA Detection Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Cell-free Tumor DNA Detection Consumption Value Market Share by Region in 2022
Figure 18. North America Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Cell-free Tumor DNA Detection Revenue Share by Players in 2022
Figure 24. Cell-free Tumor DNA Detection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Cell-free Tumor DNA Detection Market Share in 2022
Figure 26. Global Top 6 Players Cell-free Tumor DNA Detection Market Share in 2022
Figure 27. Global Cell-free Tumor DNA Detection Consumption Value Share by Type (2018-2023)
Figure 28. Global Cell-free Tumor DNA Detection Market Share Forecast by Type (2024-2029)
Figure 29. Global Cell-free Tumor DNA Detection Consumption Value Share by Application (2018-2023)
Figure 30. Global Cell-free Tumor DNA Detection Market Share Forecast by Application (2024-2029)
Figure 31. North America Cell-free Tumor DNA Detection Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Cell-free Tumor DNA Detection Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Cell-free Tumor DNA Detection Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Cell-free Tumor DNA Detection Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Cell-free Tumor DNA Detection Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Cell-free Tumor DNA Detection Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 41. France Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Cell-free Tumor DNA Detection Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Cell-free Tumor DNA Detection Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Cell-free Tumor DNA Detection Consumption Value Market Share by Region (2018-2029)
Figure 48. China Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 51. India Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Cell-free Tumor DNA Detection Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Cell-free Tumor DNA Detection Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Cell-free Tumor DNA Detection Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Cell-free Tumor DNA Detection Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Cell-free Tumor DNA Detection Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Cell-free Tumor DNA Detection Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 65. Cell-free Tumor DNA Detection Market Drivers
Figure 66. Cell-free Tumor DNA Detection Market Restraints
Figure 67. Cell-free Tumor DNA Detection Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Cell-free Tumor DNA Detection in 2022
Figure 70. Manufacturing Process Analysis of Cell-free Tumor DNA Detection
Figure 71. Cell-free Tumor DNA Detection Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Cell-free Tumor DNA Detection Picture
Figure 2. Global Cell-free Tumor DNA Detection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Cell-free Tumor DNA Detection Consumption Value Market Share by Type in 2022
Figure 4. Droplet Digital Polymerase Chain Reaction
Figure 5. Tagged-Amplicon Deep Sequencing
Figure 6. Others
Figure 7. Global Cell-free Tumor DNA Detection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Cell-free Tumor DNA Detection Consumption Value Market Share by Application in 2022
Figure 9. Breast Cancer Picture
Figure 10. Stomach Cancer Picture
Figure 11. Liver Cancer Picture
Figure 12. Other Picture
Figure 13. Global Cell-free Tumor DNA Detection Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Cell-free Tumor DNA Detection Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Cell-free Tumor DNA Detection Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Cell-free Tumor DNA Detection Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Cell-free Tumor DNA Detection Consumption Value Market Share by Region in 2022
Figure 18. North America Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Cell-free Tumor DNA Detection Revenue Share by Players in 2022
Figure 24. Cell-free Tumor DNA Detection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Cell-free Tumor DNA Detection Market Share in 2022
Figure 26. Global Top 6 Players Cell-free Tumor DNA Detection Market Share in 2022
Figure 27. Global Cell-free Tumor DNA Detection Consumption Value Share by Type (2018-2023)
Figure 28. Global Cell-free Tumor DNA Detection Market Share Forecast by Type (2024-2029)
Figure 29. Global Cell-free Tumor DNA Detection Consumption Value Share by Application (2018-2023)
Figure 30. Global Cell-free Tumor DNA Detection Market Share Forecast by Application (2024-2029)
Figure 31. North America Cell-free Tumor DNA Detection Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Cell-free Tumor DNA Detection Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Cell-free Tumor DNA Detection Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Cell-free Tumor DNA Detection Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Cell-free Tumor DNA Detection Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Cell-free Tumor DNA Detection Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 41. France Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Cell-free Tumor DNA Detection Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Cell-free Tumor DNA Detection Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Cell-free Tumor DNA Detection Consumption Value Market Share by Region (2018-2029)
Figure 48. China Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 51. India Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Cell-free Tumor DNA Detection Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Cell-free Tumor DNA Detection Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Cell-free Tumor DNA Detection Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Cell-free Tumor DNA Detection Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Cell-free Tumor DNA Detection Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Cell-free Tumor DNA Detection Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Cell-free Tumor DNA Detection Consumption Value (2018-2029) & (USD Million)
Figure 65. Cell-free Tumor DNA Detection Market Drivers
Figure 66. Cell-free Tumor DNA Detection Market Restraints
Figure 67. Cell-free Tumor DNA Detection Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Cell-free Tumor DNA Detection in 2022
Figure 70. Manufacturing Process Analysis of Cell-free Tumor DNA Detection
Figure 71. Cell-free Tumor DNA Detection Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
